Jerry McCormick, a 57-year-old San Diego journalist, was diagnosed with prostate cancer after an annual exam and has since been documenting his experience on Substack to educate others, while also ...

Black Californians are five times more likely than others to die of prostate cancer. Gov. Gavin Newsom vetoed a bill that ...

Jerry McCormick’s path to recover from prostate cancer has been anything but linear. Documenting progress and setbacks helps ...

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 ...

MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...

Up to 105 Japanese men will be enrolled at 11 sites, with data aimed at supporting a future marketing authorisation submission.

Prosecutors say First Brand founder Patrick James and his brother Edward James, a high-level executive, James used fake invoices and inflated assets to fleece lenders out of billions before 2025 ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in the Phase 3 registration study of TLX591-Px (Illuccix, Kit for the preparation ...

MELBOURNE, Australia, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programme Dr Kenrick Ng, Medical Oncology Consultant, St Bartholomew's Hospital, ...